Chinese Society of Clinical Oncology(CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021(English version)
被引量:19
摘要
1. General guidelines2. Diagnosis3. Staging4. Treatment4.1 Diffuse large B-cell lymphoma(DLBCL)4.2 Follicular lymphoma(FL)4.3 Mantle cell lymphoma(MCL)4.4 Marginal zone lymphoma(MZL)4.5 Burkitt lymphoma(BL)4.6 CLL/Small lymphocytic lymphoma(SLL)4.7 Extra-nodal natural killer/T-cell lymphoma(ENKTCL), nasal type4.8 Peripheral T-cell lymphoma(PTCL)4.9 HL4.10 Primary central nervous system lymphoma5. Prognosis Lymphomas are a group of heterogeneous diseases.
参考文献4
-
1Zhitao Ying,Lan Mi,Nina Zhou,Xuejuan Wang,Zhi Yang,Yuqin Song,Xiaopei Wang,Wen Zheng,Ningjing Lin,Meifeng Tu,Yan Xie,Lingyan Ping,Chen Zhang,Weiping Liu,Lijuan Deng,Jun Zhu.Prognostic value of ^(18)F-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation[J].Chinese Journal of Cancer Research,2019,31(1):162-170. 被引量:2
-
2Jun Cai,Panpan Liu,Huiqiang Huang,Yajun Li,Shuyun Ma,Hui Zhou,Xiaopeng Tian,Yuchen Zhang,Yan Gao,Yi Xia,Xuanye Zhang,Hang Yang,Lirong Li,Qingqing Cai.Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma[J].Signal Transduction and Targeted Therapy,2020,5(1):1-9. 被引量:8
-
3National Health Commission of the People's Republic of China.Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018(English version)[J].Chinese Journal of Cancer Research,2019,31(2):223-258. 被引量:26
-
4Weiping Liu,Jun Zhu.Comments on Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018(English version)[J].Chinese Journal of Cancer Research,2019,31(5):738-739. 被引量:4
二级参考文献4
-
1Shuna Yao,Junbo Li,Zhihua Yao,Yuanlin Xu,Junfeng Chu,Jiuyang Zhang,Shuiling Jin,Yangyang Huang,Jianbo Zhang,Jie Ma,Yan Zhao,Shujun Yang,Yanyan Liu.Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options[J].Chinese Journal of Cancer Research,2017,29(1):57-65. 被引量:3
-
2Zhitao Ying,Lan Mi,Xuejuan Wang,Yuewei Zhang,Zhi Yang,Yuqin Song,Xiaopei Wang,WenZheng,Ningjing Lin,Meifeng Tu,Yan Xie,Lingyan Ping,Chen Zhang,Weiping Liu,LijuanDeng,Jun Zhu.Prognostic value of pre-and post-transplantation 18F-fluorodeoxyglucose positron emission tomography results in non-Hodgkin lymphoma patients receiving autologous stem cell transplantation[J].Chinese Journal of Cancer Research,2017,29(6):561-571. 被引量:3
-
3应志涛,米岚,王雪鹃,张玥伟,杨志,宋玉琴,王小沛,郑文,林宁晶,涂梅峰,谢彦,平凌燕,张晨,刘卫平,邓丽娟,朱军.^18F-FDG PET-CT评估在接受白体造血干细胞移植的弥漫大B细胞淋巴瘤患者中的预后意义[J].中华血液学杂志,2018,39(5):382-386. 被引量:3
-
4National Health Commission of the People's Republic of China.Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018(English version)[J].Chinese Journal of Cancer Research,2019,31(2):223-258. 被引量:26
共引文献36
-
1Yuan Feng,Nan Wu.Management guidelines for esophageal carcinoma 2018: Chinese standards in clinical practice[J].Chinese Journal of Cancer Research,2019,31(3):421-422. 被引量:2
-
2Weiping Liu,Jun Zhu.Comments on Chinese guidelines for diagnosis and treatment of malignant lymphoma 2018(English version)[J].Chinese Journal of Cancer Research,2019,31(5):738-739. 被引量:4
-
3Xue Bai,Lili Mao,Jun Guo.Comments on Chinese guidelines for diagnosis and treatment of melanoma 2018(English version)[J].Chinese Journal of Cancer Research,2019,31(5):740-741. 被引量:1
-
4赵峰,朱军,郭楠楠,刘燕文.3.0T MRI对新辅助化疗后食管癌术前T分期的准确性及组织病理学相关性[J].临床与病理杂志,2019,39(12):2720-2726. 被引量:5
-
5赵楠楠,秦文,韩永焕,鲁静,李亚敏,徐亚君.SOX11抑制食管癌细胞增殖和迁移的机制研究[J].实用肿瘤学杂志,2020,34(1):17-23. 被引量:3
-
6吴彦明.闭合复位加压空心螺钉内固定在股骨颈骨折临床治疗中的应用[J].系统医学,2020,5(9):24-26.
-
7孙静,王铸.ADC值对食管癌T分期及病理分级的诊断价值[J].磁共振成像,2020,11(7):531-534. 被引量:6
-
8李姗姗,林征,马明阳,苏昆卉,陈雅婷,刘永兰,胡志坚.食管鳞癌术后化疗与副作用关联性[J].中华疾病控制杂志,2020,24(7):808-813. 被引量:4
-
9Ningjing Lin,Yuqin Song,Jun Zhu.Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives[J].Chinese Journal of Cancer Research,2020,32(3):303-318. 被引量:4
-
10刘璇,陈丽青,张盈盈,齐玲玲,金明姬,高钟镐,黄伟.瘤内注射PD-L1-siRNA苯硼酸-壳寡糖纳米粒抑制黑色素瘤的初步研究[J].国际药学研究杂志,2020,47(8):638-644.
同被引文献69
-
1杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1450
-
2Abrey LE Batchelor TT Ferreri A J Gospodarowicz M Pulczynski EJ Zucca E Smith JR Korfel A Soussain C DeAngelis LM Neuwelt EA O′Neill BP Thiel E Shenkier T Graus F van den Bent M Seymour JF Poortmans P Armitage JO Cavalli F.Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.[J].中国神经肿瘤杂志,2005,3(3):182-182. 被引量:57
-
3刘卫平,郑文,王小沛,宋玉琴,谢彦,涂梅峰,林宁晶,平凌燕,应志涛,邓丽娟,张晨,朱军.405例非霍奇金淋巴瘤患者乙型肝炎病毒感染率分析[J].中华血液学杂志,2011,32(8):521-524. 被引量:27
-
4陆紫媛,肖扬,李力,王耀春.TNF-α通过ERK信号通路刺激骨髓间充质干细胞表达VCAM-1[J].中国实验血液学杂志,2013,21(6):1568-1571. 被引量:5
-
5熊珊珊,石英英,石汉平.活性氧与肿瘤研究进展[J].中华肿瘤防治杂志,2014,21(13):1045-1048. 被引量:42
-
6汤士芳,余利,祁静.个案管理在淋巴瘤患者治疗与康复护理中的应用研究[J].现代医学,2014,42(8):950-952. 被引量:4
-
7王东,梁旺,段笑微,刘玲,申浩,彭永济,李宾.中国6364例结直肠癌患者 KRAS 基因突变检测分析[J].中华病理学杂志,2014,43(9):583-587. 被引量:5
-
8李雁,周云峰,梁寒,王华庆,郝继辉,朱正纲,万德森,钦伦秀,崔书中,季加孚,徐惠绵,魏少忠,许洪斌,锁涛,杨树军,谢丛华,杨肖军,杨国樑.细胞减灭术加腹腔热灌注化疗治疗腹膜表面肿瘤的专家共识[J].中国肿瘤临床,2015,42(4):198-206. 被引量:106
-
9古建燕.手术室护理安全隐患原因与安全管理应用研究进展[J].全科护理,2015,13(10):884-887. 被引量:18
-
10聂宝,黄欣,刘校龙,李敏,林梦,刘翠苓,高子芬.65例睾丸非霍奇金淋巴瘤的临床病理学特征[J].中华血液学杂志,2015,36(9):765-769. 被引量:13
引证文献19
-
1Lin Gui,Junning Cao,Dongmei Ji,Huilai Zhang,Qian Fan,Jun Zhu,Yuqin Song,Shiyu Jiang,Zhiqiang Ning,Jia Yu,Yuankai Shi.Chidamide combined with cyclophosphamide,doxorubicin,vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma[J].Chinese Journal of Cancer Research,2021,33(5):616-626. 被引量:3
-
2刘玉珂,蒲琦瑶,谭然,吴博文,李继伟,岳保红.流式细胞术监测循环弥漫大B淋巴瘤细胞数量与髓内瘤细胞负荷相关性分析及临床意义[J].中华检验医学杂志,2021,44(12):1153-1162. 被引量:2
-
3Zhitao Ying,Ting He,Shanzhao Jin,Xiaopei Wang,Wen Zheng,Ningjing Lin,Meifeng Tu,Yan Xie,Lingyan Ping,Weiping Liu,Lijuan Deng,Yanping Ding,Xuelian Hu,Bing Bu,Xin’an Lu,Yuqin Song,Jun Zhu.A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma[J].Chinese Journal of Cancer Research,2022,34(1):53-62. 被引量:2
-
4范晓娜,陈卓,李志伟.免疫检查点抑制剂在结直肠癌临床应用中的困境、研究现状与思考[J].结直肠肛门外科,2022,28(4):331-336. 被引量:1
-
5于慧,朱军.淋巴瘤的新药治疗[J].临床血液学杂志,2022,35(9):616-620.
-
6石子旸,王玥,施晴,王硕,张慕晨,沈容,赫洋,裘惠玲,易红梅,董磊,王黎,程澍,许彭鹏,赵维莅.女性生殖系统弥漫大B细胞淋巴瘤患者临床病理特征及预后分析[J].白血病.淋巴瘤,2022,31(9):527-532. 被引量:1
-
7许康节,詹万达,万晓洁,王杰,戴华.WWOX促进弥漫性大B淋巴瘤增殖作用初探[J].扬州大学学报(农业与生命科学版),2022,43(6):80-86.
-
8马珊珊,张旭东,汪文华,王妍杰,刘栋林,张明智.奥布替尼维持治疗对老年或体弱中枢神经系统淋巴瘤患者的疗效和安全性分析[J].现代肿瘤医学,2023,31(7):1315-1320.
-
9秦悦,刘蓉萍,张效楠,张湾,任陈,吴德华.原发性中枢神经系统淋巴瘤复发或进展模式的回顾性、单中心分析:是否可以替换全脑放疗?[J].南方医科大学学报,2023,43(4):499-506.
-
10王方策,李萍,梁爱斌.血液肿瘤中CAR-T细胞疗法的现状及优化策略[J].中华内科杂志,2023,62(6):581-586. 被引量:1
二级引证文献11
-
1刘贵建,王卉.流式细胞术在造血和淋巴组织肿瘤诊疗中应用的思考[J].中华检验医学杂志,2021,44(12):1097-1100. 被引量:2
-
2郑浩东,王玉红,郭凌川.血管免疫母细胞性T细胞淋巴瘤临床病理及分子遗传与治疗研究进展[J].中华病理学杂志,2023,52(2):189-193. 被引量:1
-
3梁书洁,耿素霞,赖沛龙,杜欣.2022年CAR-T细胞在血液肿瘤治疗的研究进展[J].循证医学,2022,22(6):340-349.
-
4张茜,陈焕伟,吕学文,李晟,戴伟平,梁业由.P53、PDL1在弥漫大B细胞淋巴瘤中的表达相关性及其对预后的影响[J].罕少疾病杂志,2023,30(7):103-105. 被引量:2
-
5邵晓倩,李杰,王谧,师凌云,于晓燕.基于微信的自我报告和互动平台在鼻咽癌放化疗患者中的应用效果[J].吉林医学,2023,44(9):2572-2575.
-
6刘帅,魏园玉,乔婷婷,刘玉珂,蒲琦瑶,王笑乾,袁小庚,岳保红.骨髓淋巴瘤细胞形态特征及数量在弥漫大B细胞淋巴瘤预后评估中的价值[J].中华检验医学杂志,2023,46(9):925-933.
-
7宁静,杨建伟,姚志华,陈辉.外周T细胞淋巴瘤患者化疗后并发医院肺部感染的相关因素[J].河南医学研究,2023,32(19):3471-3474.
-
8熊戴群,刘少龙,叶欣华.西达本胺联合PD-1抑制剂治疗晚期三阴型乳腺癌的疗效及安全性[J].赣南医学院学报,2023,43(8):777-780.
-
9吕浩晗,郑文静,王延峰,王涛.具有中央记忆T细胞表型的新型CAR-T细胞的制备及其对GD2阳性人骨肉瘤细胞的杀伤作用[J].细胞与分子免疫学杂志,2023,39(10):872-877.
-
10丁倩,王谦,张怡,梁宇光,郭春彦.儿科人群嵌合抗原受体T细胞免疫疗法临床研究现状与分析[J].中国医院用药评价与分析,2023,23(12):1462-1466. 被引量:1
-
1程岗,杨帆,李庆岗,赵明明,李海龙,王鹏,张剑宁.原发性中枢神经系统淋巴瘤MTHFR基因多态性对甲氨蝶呤代谢的影响[J].中国微侵袭神经外科杂志,2021,26(2):49-52. 被引量:1
-
2何京美,黄德晖,吴卫平.原发性中枢神经系统淋巴瘤的临床特点和影像特征分析[J].解放军医学院学报,2021,42(3):291-296. 被引量:8
-
3赖文普,郑润辉,覃鹏飞,王春燕,黄振倩,刘丹,汪雅涯,李海明,彭思达,谭获,罗晓丹.西达本胺联合化疗治疗外周T细胞淋巴瘤的疗效研究[J].中国实用医药,2021,16(19):25-27. 被引量:1
-
4Adrien Mougougou,Steevy Ndang Ngou Milama,Smith Giscard Olagui,Jean Massandé Mouyendi.Prostatic Burkitt Lymphoma, a Rare Secondary Location[J].Open Journal of Urology,2021,11(6):226-231.
-
5Liang Wang,Xi-wen Bi,Yu-jia Zhu,Ying-zhi He,Qiu-yu Lai,Zhong-jun Xia,Qing-qing Cai.IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma[J].Cancer Communications,2018,38(1):667-676. 被引量:4
-
6Xiaoguang Wang,Brittany C.Waschke,Rachel A.Woolaver,Samantha M.Y.Chen,Zhangguo Chen,Jing H.Wang.MHC class Ⅰ-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells[J].Cellular & Molecular Immunology,2021,18(3):723-734. 被引量:4
-
7Hong Xia Xu,Chun Hua Song,Zhen Ming Fu,Chang Wang,Zeng Qing Guo,Yuan Lin,Ying Ying Shi,Wen Hu,Yi Ba,Su Yi Li,Zeng Ning Li,Kun Hua Wang,Jing Wu,Ying He,Jia Jun Yang,Cong Hua Xie,Fu Xiang Zhou,Xin Xia Song,Gong Yan Chen,Wen Jun Ma,Su Xia Luo,Zi Hua Chen,Ming Hua Cong,Hu Ma,Chun Ling Zhou,Wei Wang,Qi Luo,Yong Mei Shi,Yu Mei Qi,Hai Ping Jiang,Wen Xian Guan,Jun Qiang Chen,Jia Xin Chen,Yu Fang,Lan Zhou,Yong Dong Feng,Rong Shao Tan,Tao Li,Jun Wen Ou,Qing Chuan Zhao,Jian Xiong Wu,Min Weng,Qing Hua Yao,Jiu Wei Cui,Wei Li,Han Ping Shi,the Investigation on Nutrition Status and Clinical Outcome of Common Cancers(INSCOC)Group.Malnutrition and Quality of Life in Chinese Cancer Patients: a Clinical Study of 23,994 Subjects[J].Journal of Nutritional Oncology,2021,6(1):16-32. 被引量:8
-
8Hwei-Fang Tsai,Ping-Ning Hsu.Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology[J].Cellular & Molecular Immunology,2010,7(4):255-259. 被引量:8
-
9李玉,刘俐惠,闫荣,苏春香,郭红,李小玉,岳树锦.中文版头颈癌信息需求问卷应用于患者及照顾者的信效度分析[J].International Journal of Nursing Sciences,2021,8(3):354-360. 被引量:1
-
10Fahad Saqib Lodhi,Aymen M Elsous,Saadia Irum,Adeel Ahmed Khan,Unaib Rabbani.Psychometric properties of the Urdu version of the Hospital Anxiety and Depression Scale(HADS)among pregnant women in Abbottabad,Pakistan[J].General Psychiatry,2020,33(5):311-318. 被引量:1